B12 deficiency is associated with depression, cognitive impairment, irritability, and in severe cases, psychosis
BPC-157 does not belong in that category
This dual mechanism is why tirzepatide consistently outperforms single-target GLP-1 medications like semaglutide in head-to-head comparisons
pylori positive subjects are dyspeptic or asymptomatic and could not be driven by convincing motivations, since the eradication of the bacterium is often not accompanied by a clinical benefit (Zullo et al., 2014)
The largest human trial had only 16 test subjects, which means that if BPC-157 had, say, a 1% risk of a truly catastrophic side effect, a test like that would have a very small chance of catching it